1 / 7

Shalev V, et al. Arch Intern Med 2009; 169:260-268

Shalev V, et al. Arch Intern Med 2009; 169:260-268. Characteristics of Adults Initiating a New Treatment With a Statin Agent, Maccabi Healthcare Services, Israel, 1998-2006 – Part I. Shalev V, et al. Arch Intern Med 2009; 169:260-268.

stamos
Download Presentation

Shalev V, et al. Arch Intern Med 2009; 169:260-268

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Shalev V, et al. Arch Intern Med 2009; 169:260-268

  2. Characteristics of Adults Initiating a New Treatment With a Statin Agent, Maccabi Healthcare Services, Israel, 1998-2006 – Part I Shalev V, et al. Arch Intern Med 2009; 169:260-268

  3. Characteristics of Adults Initiating a New Treatment With a Statin Agent, Maccabi Healthcare Services, Israel, 1998-2006 – Part II Shalev V, et al. Arch Intern Med 2009; 169:260-268

  4. Association Between Potential Determinants and All-Cause Mortality, Maccabi Healthcare Services, Israel, 1998-2006 Shalev V, et al. Arch Intern Med 2009; 169:260-268

  5. Proportional effects of continuation of statins on reduction in all-cause mortality per 10% proportion of days covered with statins in primary prevention (A) and secondary prevention (B) cohorts Shalev V, et al. Arch Intern Med 2009; 169:260-268

  6. Proportion of Days Covered With Statins and All-Cause Mortality, Maccabi Healthcare Services, Israel, 1998-2006 Shalev V, et al. Arch Intern Med 2009; 169:260-268

  7. Hazard ratios and 95% confidence intervals of all-cause mortality according to proportion of days covered with statins in primary prevention (A) and secondary prevention (B) cohorts, Maccabi Healthcare Services, Israel, 1998-2006 Shalev V, et al. Arch Intern Med 2009; 169:260-268

More Related